The use of proteomics for the assessment of clinical samples in research

Clinical Biochemistry

Volumn 37, Issue 11, 2004, Pages 943-952

  Aldred, Sarah ^a   Grant, Melissa M ^b   Griffiths, Helen R ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

2 DE; Clinical proteomics; Mass spectrometry; Proteomics

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN; CREATINE KINASE BB; CYTOCHROME C OXIDASE; GLUTAMATE AMMONIA LIGASE; GLUTATHIONE TRANSFERASE; HEMOGLOBIN; KERATIN; PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UBIQUITIN THIOLESTERASE;

ALZHEIMER DISEASE; ANALYTIC METHOD; BIOPSY; BLOOD CELL; BLOOD DISEASE; BLOOD SAMPLING; BODY FLUID; CELL LINE; CEREBROSPINAL FLUID; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; COMPARATIVE STUDY; DESORPTION; DIAGNOSTIC PROCEDURE; DISEASE CONTROL; DISEASE MARKER; DYNAMICS; ELECTROPHORESIS; ELECTROSPRAY MASS SPECTROMETRY; EXPERIMENT; GEL ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IONIZATION; LASER; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; RHEUMATOID ARTHRITIS; SALIVA; SAMPLE; SURFACE PROPERTY; TECHNOLOGY; TISSUE; URINE;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; CLINICAL LABORATORY TECHNIQUES; HUMANS; PROTEOMICS;

EID: 6344284935     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.09.002     Document Type: Review

References (81)

1. N.G. Anderson, and N.L. Anderson Twenty years of two-dimensional electrophoresis: past, present and future Electrophoresis 17 1996 443 453
2. M.D. Person, T.J. Monks, and S.S. Lau An integrated approach to identifying chemically induced posttranslational modifications using comparative MALDI-MS and targeted HPLC-ESI-MS/MS Chem. Res. Toxicol. 16 2003 598 608
3. F. Karpe, and A. Hamsten Determination of apolipoproteins B-48 and B-100 in trigylceride-rich lipoproteins by analytical SDS-PAGE J. Lipid Res. 35 1994 1311 1317
4. J.L. McDonough, I. Neverova, and J.E. Van Eyk Proteomic analysis of human biopsy samples by single two-dimensional electrophoresis: Coomassie, silver, mass spectrometry, and Western blotting Proteomics 2 2002 978 987
5. Bhakdi S FAU- Knufermann, Knufermann, HF, Wallach, DF, Two-dimensional separation of erythrocyte membrane proteins.
6. A.V. Emes, A.L. Latner, and J.A. Martin Electrofocusing followed by gradient electrophoresis: a two-dimensional polyacrylamide gel technique for the separation of proteins and its application to the immunoglobulins Clin. Chim. Acta 64 1975 69 78
7. D.S. Young, and R.P. Tracy Clinical applications of two-dimensional electrophoresis J. Chromatogr., A 698 1995 163 179
8. H. Zhu, S. Pan, S. Gu, E.M. Bradbury, and X. Chen Amino acid residue specific stable isotope labeling for quantitative proteomics Rapid Commun. Mass Spectrom. 16 2002 2115 2123
9. A. Sickmann, J. Reinders, Y. Wagner, C. Joppich, R. Zahedi, and H.E. Meyer The proteome of Saccharomyces cerevisiae mitochondria Proc. Natl. Acad. Sci. U. S. A. 100 2003 13207 13212
10. E.P. Diamandis Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations Mol. Cell Proteomics 2004
11. K.D. Rodland Proteomics and cancer diagnosis: the potential of mass spectrometry Clin. Biochem. 37 2004 579 583
12. D.E. Garfin Two-dimensional gel electrophoresis: an overview TrAC, Trends Anal. Chem. 22 2003 263 272
13. R. Wildgruber, A. Harder, C. Obermaier, G. Boguth, W. Weiss, and S.J. Fey Towards higher resolution: two-dimensional electrophoresis of Saccharomyces cerevisiae proteins using overlapping narrow immobilized pH gradients Electrophoresis 21 2000 2610 2616
14. M. Puchades, S.F. Hansson, C.L. Nilson, N. Andreasen, K. Blennow, and P. Davidsson Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease Brain Res. Mol. Brain Res. 118 2003 140 146
15. A. Gorg, C. Obermaier, G. Boguth, A. Harder, B. Scheibe, and R. Wildgruber The current state of two-dimensional electrophoresis with immobilized pH gradients Electrophoresis 21 2000 1037 1053
16. N.L. Anderson, and N.G. Anderson The human plasma proteome: history, character, and diagnostic prospects Mol. Cell Proteomics 1 2002 845 867
17. P.G. Righetti, A. Castagna, F. Antonucci, C. Piubelli, D. Cecconi, and N. Campostrini The proteome: Anno Domini 2002 Clin. Chem. Lab. Med. 41 2003 425 438
18. N. Ahmed, G. Barker, K. Oliva, D. Garfin, K. Talmadge, and H. Georgiou An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum Proteomics 3 2003 1980 1987
19. R. Pieper, Q. Su, C.L. Gatlin, S.T. Huang, N.L. Anderson, and S. Steiner Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome Proteomics 3 2003 422 432
20. B.A. Lollo, S. Harvey, J. Liao, A.C. Stevens, R. Wagenknecht, and R. Sayen Improved two-dimensional gel electrophoresis representation of serum proteins by using ProtoClear Electrophoresis 20 1999 854 859
21. E. Gianazza, and P. Arnaud Chromatography of plasma proteins on immobilized Cibacron Blue F3-GA. Mechanism of the molecular interaction Biochem. J. 203 1982 637 641
22. S.T. Thompson, K.H. Cass, and E. Stellwagen Blue dextran-sepharose: an affinity column for the dinucleotide fold in proteins Proc. Natl. Acad. Sci. U. S. A. 72 1975 669 672
23. T. Voss, and P. Haberl Observations on the reproducibility and matching efficiency of two-dimensional electrophoresis gels: consequences for comprehensive data analysis Electrophoresis 21 2000 3345 3350
24. A.T. Rosengren, J.M. Salmi, T. Aittokallio, J. Westerholm, R. Lahesmaa, and T.A. Nyman Comparison of PDQuest and Progenesis software packages in the analysis of two-dimensional electrophoresis gels Proteomics 3 2003 1936 1946
25. B. Raman, A. Cheung, and M.R. Marten Quantitative comparison and evaluation of two commercially available, two-dimensional electrophoresis image analysis software packages, Z3 and Melanie Electrophoresis 23 2002 2194 2202
26. M. Mann, S.E. Ong, M. Gronborg, H. Steen, O.N. Jensen, and A. Pandey Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome Trends Biotechnol. 20 2002 261 268
27. H. Zhang, X. Zha, Y. Tan, P.V. Hornbeck, A.J. Mastrangelo, and D.R. Alessi Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs J. Biol. Chem. 277 2002 39379 39387
28. M. Gronborg, T.Z. Kristiansen, A. Stensballe, J.S. Andersen, O. Ohara, and M. Mann A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate Mol. Cell Proteomics 1 2002 517 527
29. D.E. Kalume, H. Molina, and A. Pandey Tackling the phosphoproteome: tools and strategies Curr. Opin. Chem. Biol. 7 2003 64 69
30. A. Yamagata, D.B. Kristensen, Y. Takeda, Y. Miyamoto, K. Okada, and M. Inamatsu Mapping of phosphorylated proteins on two-dimensional polyacrylamide gels using protein phosphatase Proteomics 2 2002 1267 1276
31. V. Soskic, M. Gorlach, S. Poznanovic, F.D. Boehmer, and J. Godovac-Zimmermann Functional proteomics analysis of signal transduction pathways of the platelet-derived growth factor beta receptor Biochemistry 38 1999 1757 1764
32. P. Ghezzi, and V. Bonetto Redox proteomics: identification of oxidatively modified proteins Proteomics 3 2003 1145 1153
33. R.L. Levine, J.A. Williams, E.R. Stadtman, and E. Shacter Carbonyl assays for determination of oxidatively modified proteins Methods Enzymol. 233 1994 346 357
34. E. Shacter, J.A. Williams, M. Lim, and R.L. Levine Differential susceptibility of plasma proteins to oxidative modification: examination by Western blot immunoassay Free Radical Biol. Med. 17 1994 429 437
35. A. Nakamura, and S. Goto Analysis of protein carbonyls with 2,4-dinitrophenyl hydrazine and its antibodies by immunoblot in two-dimensional gel electrophoresis J. Biochem. (Tokyo) 119 1996 768 774
36. R.T. Dean, S. Fu, R. Stocker, and M.J. Davies Biochemistry and pathology of radical-mediated protein oxidation Biochem. J. 324 Pt 1 1997 1 18
37. G. Nikov, V. Bhat, J.S. Wishnok, and S.R. Tannenbaum Analysis of nitrated proteins by nitrotyrosine-specific affinity probes and mass spectrometry Anal. Biochem. 320 2003 214 222
38. W. Ying, Y. Hao, Y. Zhang, W. Peng, E. Qin, and Y. Cai Proteomic analysis on structural proteins of Severe Acute Respiratory Syndrome coronavirus Proteomics 4 2004 492 504
39. A.R. Salomon, S.B. Ficarro, L.M. Brill, A. Brinker, Q.T. Phung, and C. Ericson Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry Proc. Natl. Acad. Sci. U. S. A. 100 2003 443 448
40. A.R. Hesketh, G. Chandra, A.D. Shaw, J.J. Rowland, D.B. Kell, and M.J. Bibb Primary and secondary metabolism, and post-translational protein modifications, as portrayed by proteomic analysis of Streptomyces coelicolor Mol. Microbiol. 46 2002 917 932
41. M.R. Wilkins, E. Gasteiger, A.A. Gooley, B.R. Herbert, M.P. Molloy, and P.A. Binz High-throughput mass spectrometric discovery of protein post-translational modifications J. Mol. Biol. 289 1999 645 657
42. N. Mistry, I. Podmore, M. Cooke, P. Butler, H. Griffiths, and K. Herbert Novel monoclonal antibody recognition of oxidative DNA damage adduct, deoxycytidine-glyoxal Lab. Invest. 83 2003 241 250
43. G.V. Kryukov, S. Castellano, S.V. Novoselov, A.V. Lobanov, O. Zehtab, and R. Guigo Characterization of mammalian selenoproteomes Science 300 2003 1439 1443
44. J.D. Tissot, P. Schneider, R.W. James, R. Daigneault, and D.F. Hochstrasser High-resolution two-dimensional protein electrophoresis of pathological plasma/serum Appl. Theor. Electrophor. 2 1991 7 12
45. N.S. Doherty, B.H. Littman, K. Reilly, A.C. Swindell, J.M. Buss, and N.L. Anderson Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two dimensional gel electrophoresis Electrophoresis 19 1998 355 363
46. R.S. Boyd, P.J. Adam, S. Patel, J.A. Loader, J. Berry, and N.T. Redpath Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B Leukemia 17 2003 1605 1612
47. P.J. Adam, R. Boyd, K.L. Tyson, G.C. Fletcher, A. Stamps, and L. Hudson Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer J. Biol. Chem. 278 2003 6482 6489
48. S. Lehrer, J. Roboz, H. Ding, S. Zhao, E.J. Diamond, and J.F. Holland Putative protein markers in the sera of men with prostatic neoplasms BJU Int. 92 2003 223 225
49. A.J. Rai, Z. Zhang, J. Rosenzweig, I. Shih, T. Pham, and E.T. Fung Proteomic approaches to tumor marker discovery Arch. Pathol. Lab. Med. 126 2002 1518 1526
50. C.S. Mitsiades, N. Mitsiades, S.P. Treon, and K.C. Anderson Proteomic analyses in Waldenstrom's macroglobulinemia and other plasma cell dyscrasias Semin. Oncol. 30 2003 156 160
51. J. Choi, C. Malakowsky, J. Talent, C. Conrad, and R.W. Gracy Identification of oxidised plasma proteins in Alzheimer's disease Biochem. Biophys. Res. Commun. 293 2002 1566 1570
52. R. Strohmeyer, and J. Rogers Molecular and cellular mediators of Alzheimer's disease inflammation J. Alzheimer's Dis. 3 2001 131 157
53. K.M. Mattila, and H. Frey Biomarkers in Alzheimer's disease? Pathol. Biol. (Paris) 44 1996 685 688
54. N. Imam-Sghiouar, I. Laude-Lemaire, V. Labas, D. Pflieger, J.P. Le Caer, and M. Caron Subproteomics analysis of phosphorylated proteins: application to the study of B-lymphoblasts from a patient with Scott syndrome Proteomics 2 2002 828 838
55. D. Terry, and D. Desiderio Between gel reproducibility of the human cerebrospinal fluid proteome Proteomics 3 2003 1962 1979
56. P. Davidsson, A. Westman-Brinkmalm, C.L. Nilsson, M. Lindbjer, L. Paulson, and N. Andreasen Proteome analysis of cerebrospinal fluid proteins in Alzhiemer's patients NeuroReport 13 2002 611 615
57. R.A. Samatovicz Genetics and brain injury: apolipoprotein E J. Head Trauma Rehabil. 15 2000 869 874
58. W. Marz, H. Scharnagl, M. Kirca, J. Bohl, W. Gross, and T.G. Ohm Apolipoprotein E polymorphism is associated with both senile plaque load and Alzheimer-type neurofibrillary tangle formation Ann. N. Y. Acad. Sci. 777 1996 276 280
59. C. Hesse, C.L. Nilsson, K. Blennow, and P. Davidsson Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization- time of flight-mass spectrometry Electrophoresis 22 2001 1834 1837
60. L. Jiang, K. Lindpaintner, H. Li, N. Gu, H. Langen, and L. He Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia Amino Acids 25 2003 49 57
61. M. Unlu, R.P. de Lange, R. de Silva, R. Kalaria, and D. St Clair Detection of complement factor B in the cerebrospinal fluid of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy disease using two-dimensional gel electrophoresis and mass spectrometry Neurosci. Lett. 282 2000 149 152
62. P.R. Jungblut, E. Zimny-Arndt, E. Zeinddl-Eberhart, J. Stulik, K. Koupilova, and K.P. Pleiffner Proteomics in human disease: cancer, heart and infectious diseases Electrophoresis 20 1999 2100 2110
63. G. Chen, T.G. Gharib, C.C. Huang, D.G. Thomas, K.A. Shedden, and J.M. Taylor Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors Clin. Cancer Res. 8 2002 2298 2305
64. T.A. Zhukov, R.A. Johanson, A.B. Cantor, R.A. Clark, and M.S. Tockman Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry Lung Cancer 40 2003 267 279
65. B. Pauli, J. Alroy, and R. Weinstein The ultrastructure and pathobiology of urinary bladder cancer 1983 CRC Press, Inc. Boca Raton, FL 41 140
66. J.E. Celis, M. Ostergaard, B. Basse, A. Celis, J.B. Lauridsen, and G.P. Ratz Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas Cancer Res. 56 1996 4782 4790
67. M. Ostergaard, H.H. Rasmussen, H.V. Nielsen, H. Vorum, T.F. Orntoft, and H. Wolf Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation Cancer Res. 57 1997 4111 4117
68. J.E. Celis, P. Celis, M. Ostergaard, B. Basse, J.B. Lauridsen, and G. Ratz Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions Cancer Res. 59 1999 3003 3009
69. I. Skoog, R.N. Kalaria, and M.M.B. Breteler Vascular factors and Alzheimer disease Alzheimer Disease and Associated Disorders 13 1999 S106 S114
70. Y. Lhara, T. Haybara, K. Sasaki, Y. Fujisawa, R. Kawada, and T. Yamamoto Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia J. Neurol. Sci. 1997 1997 76 81
71. M. Korolainen, G. Goldsteins, I. Alafuzoff, J. Koistinaho, and T. Pirttila Proteomic analysis of protein oxidation in Alzheimer's disease brain Electrophoresis 23 2002 3428 3433
72. K.M. Mattila, and H. Frey Two-dimensional analysis of qualitative and quantitative changes in blood cell proteins in Alzheimer's disease: search for extraneuronal markers Appl. Theor. Electrophor. 4 1995 189 196
73. A. Castegna, M. Akensov, M. Akensov, V. Thongboonkerd, J. Klein, and W. Pierce Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: Creatinine kinase BB, Glutamine synthase, and Ubiquitin carboxyl terminal hydrolase L-1 Free Radical Biol. Med. 33 2002 562 571
74. A. Castegna, M. Akensov, V. Thongboonkerd, J.B. Klein, W. Pierce, and R. Booze Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II, dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71 J. Neurochem. 82 2002 1524 1532
75. P.R. Jungblut, A. Otto, E. Zeinddl-Eberhart, K.P. Pleiffner, M. Knecht, and V. Regitz-Zagrosek Protein composition of the human heart: the construction of a myocardial two-dimensional electrophoresis database Electrophoresis 15 1994 685 707
76. C. Scheler, E.C. Muller, J. Stahl, U. Muller-Werdan, J. Salnikow, and P. Jungblut Identification and characterization of heat shock protein 27 protein species in human myocardial two-dimensional electrophoresis patterns Electrophoresis 18 1997 2823 2831
77. J.A. Beeley, and K.S. Khoo Salivary proteins in rheumatoid arthritis and Sjogren's syndrome: one-dimensional and two-dimensional electrophoretic studies Electrophoresis 20 1999 1652 1660
78. S. Wittke, D. Fliser, M. Haubitz, S. Bartel, R. Krebs, and F. Hausadel Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers J. Chromatogr. 1013 2003 173 181
79. A. Vlahou, P.F. Schellhammer, S. Mendrinos, K. Patel, F.I. Kondylis, and L. Gong Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine Am. J. Pathol. 158 2001 1491 1502
80. M. Ostergaard, H. Wolf, T.F. Orntoft, and J.E. Celis Psoriasin (S100A7): a putative urinary marker for the follow-up of patients with bladder squamous cell carcinomas Electrophoresis 20 1999 349 354
81. J.E. Celis, I. Gromova, J.M. Moreira, T. Cabezon, and P. Gromov Impact of proteomics on bladder cancer research Pharmacogenomics 5 2004 381 394